Partial rescue of the full-field electroretinogram in patients with RPE65-related retinal dystrophy following gene augmentation therapy with voretigene neparvovec-rzyl
Documenta Ophthalmologica · 2024
DOI: 10.1007/s10633-024-09987-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Documenta Ophthalmologica, 2024. Verfasst von A Amato und 6 weiteren Autor:innen. Beteiligte Einrichtung: Casey Eye Institute, Oregon Health & Science University, Portland, OR, 97239, USA. Hauptthemen laut MEDLINE: Electroretinography, cis-trans-Isomerases, Genetic Therapy, Retinal Dystrophies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To present a series of patients with RPE65-related retinal dystrophy showing a partial rescue of the full-field electroretinogram (ERG) following gene replacement therapy with voretigene neparovec-rzyl (Luxturna®). METHODS: This retrospective chart review examined 17 patients treated with voretigene neparovec-rzyl (VN) at the Casey Eye Institute (2018-2022). The last pre-operative ERG and all available post-operative ERGs were analyzed to identify subjects with functional rescue. Measurements of amplitudes and implicit times were compared to data from age-matched controls and the attenuation relative to the lower limit of normal (LLN) was calculated. For comparison with other functional exams, the last pre-operative and all post-treatment best-corrected visual acuity (BCVA) data, visual field (VF) tests and full-field threshold stimulus tests (FST) were also described. RESULTS: Of patients who underwent ERGs, most had unrecordable ERGs that did not change after treatment. However, we identified three patients, treated bilaterally, who demonstrated partial rescue of the full-field ERG in both eyes which was sustained during the course of the study. CONCLUSIONS: This is the largest series of patients treated with VN showing a partial rescue of the ERG. This is also the first report of bilateral ERG rescue, as well as the first description of ERG recovery occurring in non-pediatric subjects. Full-field ERG could be used in combination with other psychophysical tests and imaging modalities to detect and deepen our understanding of the response to this gene therapy approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Casey Eye Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
- IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
- IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Casey Eye Institute, Oregon Health & Science University, Portland, OR, 97239, USA. pennesi@retinafoundation.org.
- Retina Foundation of the Southwest, 9600 N Central Pkwy, Dallas, TX, 75231, USA. pennesi@retinafoundation.org.
ORCID-Profile: M E Pennesi
Zitieren
APA
Amato, A., Tschetter, W., Everett, L., Bailey, S. T., Lauer, A. K., Yang, P., & Pennesi, M. E. (2024). Partial rescue of the full-field electroretinogram in patients with RPE65-related retinal dystrophy following gene augmentation therapy with voretigene neparvovec-rzyl. Documenta Ophthalmologica. https://doi.org/10.1007/s10633-024-09987-6
Vancouver
Amato A, Tschetter W, Everett L, Bailey ST, Lauer AK, Yang P, et al. Partial rescue of the full-field electroretinogram in patients with RPE65-related retinal dystrophy following gene augmentation therapy with voretigene neparvovec-rzyl. Documenta Ophthalmologica. 2024. doi:10.1007/s10633-024-09987-6
BibTeX
@article{Amato2024,
author = {Amato, A and Tschetter, W and Everett, L and Bailey, S T and Lauer, A K and Yang, P and Pennesi, M E},
title = {Partial rescue of the full-field electroretinogram in patients with RPE65-related retinal dystrophy following gene augmentation therapy with voretigene neparvovec-rzyl},
journal = {Documenta Ophthalmologica},
year = {2024},
doi = {10.1007/s10633-024-09987-6}
}
EUVIMED